Dimeric-(−)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathwayXiuli Sun, Cheng‐Ting Zi, Lixia Wang et al.|Chemico-Biological Interactions|2022Cited by 17
Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular DockingYa Wang, Jun Sheng, Xiaojing Shen et al.|Molecules|2021Cited by 13